Gilead launches executive hiring spree as Covid-19 treatment remdesivir shows new promise Gilead appears to be building a stable of talented executives ahead of a busy year. Joshua Fruhlinger 4.17.20 2:47 PM Markets
Regeneron social following shoots up and stock surges as pharma company may have Coronavirus treatment Regeneron shares are on the verge of hitting multi-year highs as the New York pharmaceutical company looks to quickly develop a Coronavirus treatment. Jon Marino 3.18.20 1:11 PM Innovation
Gilead Sciences doubles down on salespeople as it heads into earnings season Gilead Sciences saw a sudden drop in LinkedIn headcount growth... And dozens of salespeople positions open up. We dive into the data as it prepares to announce its Q1 earnings. James Mattone 4.29.19 1:55 PM People
The curious story of how CUSIP numbers became a Wall Street battleground CUSIP numbers are like a Dewey Decimal System for stocks and bonds. They’re also a source of illegal monopoly power, according to investor lawsuits. Doug Bailey 3.25.22 4:51 PM Markets